FULIRI Plus Targeted Therapy for First-line Conversion Therapy of Colorectal Cancer Liver Metastases.

by | Apr 7, 2026 | Clinical Trials | 0 comments

​ Conditions: Colo-rectal Cancer

Interventions: Drug: FULIRI combination targeted therapy

Sponsors: Zhongnan Hospital

Not yet recruiting Conditions: Colo-rectal Cancer
Interventions: Drug: FULIRI combination targeted therapy
Sponsors: Zhongnan Hospital
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *